Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 1/20 | 0.45 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22722985 | 0.83 | KCNN4 (0.50) | ALDH1A1ALOX15MAPTKMT2ACYP2C19 | |
| SCHEMBL5046100 | 0.83 | KCNN4 (0.50) | ALDH1A1ALOX15MAPTKMT2ACYP2C19 | |
| SCHEMBL2517938 | 0.83 | KCNN4 (0.50) | ALDH1A1ALOX15MAPTKMT2ACYP2C19 | |
| SCHEMBL11746305 | 0.82 | CES1 (0.55) | ALDH1A1ALOX15MAPTKMT2ACYP2C19 | |
| SCHEMBL3128240 | 0.81 | MAPT (0.50) | ALDH1A1ALOX15MAPTKMT2ACYP2C19 | |
| SCHEMBL420635 | 0.79 | KCNN4 (0.47) | ALDH1A1ALOX15MAPTKMT2ACYP2C19 | |
| SCHEMBL5691818 | 0.79 | PPARG (0.61) | ALDH1A1ALOX15MAPTKMT2ACYP2C19 | |
| SCHEMBL5322361 | 0.79 | CYP2C19 (0.47) | ALDH1A1ALOX15MAPTKMT2ACYP2C19 | |
| SCHEMBL8894764 | 0.79 | CYP2C19 (0.47) | ALDH1A1ALOX15MAPTKMT2ACYP2C19 | |
| SCHEMBL6898466 | 0.78 | CYP2C19 (0.46) | ALDH1A1ALOX15MAPTKMT2ACYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 303 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| WO-2026090521-A2 | METHODS FOR DETECTING AND TREATING CAVERNOUS ANGIOMA | THE UNIVERSITY OF CHICAGO (US) | 2026-04-30 | — | — | WO | claimed |
| US-20250163356-A1 | SYSTEMS AND METHODS FOR REJUVENATING CELL CULTURE MEDIUM | FUTURE MEAT TECHNOLOGIES LTD. (IL) | 2025-05-22 | — | — | US | claimed |
| EP-4537111-A2 | MULTI-OMICS ASSESSMENT | Prognomiq Inc (US) | 2025-04-16 | — | — | EP | claimed |
| CN-119816897-A | Multiple study assessment | 普罗科技有限公司 | 2025-04-11 | — | — | CN | claimed |
| WO-2025019764-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | MATTERWORKS INC (US) | 2025-01-23 | — | — | WO | claimed |
| EP-4479509-A1 | SYSTEMS AND METHODS FOR REJUVENATING CELL CULTURE MEDIUM | Future Meat Technologies Ltd. (IL) | 2024-12-25 | — | — | EP | claimed |
| CN-111308001-B | Metabolic marker for human macular neovascular diseases and application thereof | 上海市第一人民医院 | 2024-11-29 | — | — | CN | claimed |
| EP-4437319-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | Matterworks Inc (US) | 2024-10-02 | — | — | EP | claimed |
| CN-118130641-A | Metabolite composition and application thereof as well as acute myocardial infarction screening kit | 泰达国际心血管病医院 | 2024-06-04 | — | — | CN | claimed |
| US-20030180771-A1 | Electrochemically analyzing samples from selected areas of the body of living organism for elevated free levels of nucleotide excision products resulting from DNA or RNA damage | DIONEX CORPORATION | 2003-09-25 | — | — | US | claimed |
| US-20030180772-A1 | Detection of DNA damage | DIONEX CORPORATION | 2003-09-25 | — | — | US | claimed |
| EP-1341931-A2 | DETECTION OF DNA DAMAGE | ESA, Inc. (US) | 2003-09-10 | — | — | EP | claimed |
| WO-2002030266-A2 | DETECTION OF DNA DAMAGE | ESA, INC. (US) | 2002-04-18 | — | — | WO | claimed |
| CN-1082052-C | process for preparing cyclic depsipeptide compounds and novel cyclic depsipeptides | MEIJI SEIKA KAISHA (JP) | 2002-04-03 | — | — | CN | claimed |
| CN-1230182-A | Process for producing cyclodepsipeptide compounds and novel cyclodepsipeptide | MEIJI SEIKA KAISHA (JP) | 1999-09-29 | — | — | CN | claimed |
| EP-0528975-A4 | GROWTH INHIBITORS AND METHODS OF TREATING CANCER AND CELL PROLIFERATIVE DISEASES | — | 1993-09-15 | — | — | EP | claimed |
| EP-0528975-A1 | GROWTH INHIBITORS AND METHODS OF TREATING CANCER AND CELL PROLIFERATIVE DISEASES | BAYLOR COLLEGE OF MEDICINE (US) | 1993-03-03 | — | — | EP | claimed |
| WO-1993001824-A1 | COMBINATION THERAPY USING BIOFLAVONOID COMPOUNDS WITH ANTI-CANCER DRUGS | BAYLOR COLLEGE OF MEDICINE (US) | 1993-02-04 | — | — | WO | claimed |
| WO-1991017749-A1 | GROWTH INHIBITORS AND METHODS OF TREATING CANCER AND CELL PROLIFERATIVE DISEASES | BAYLOR COLLEGE OF MEDICINE (US) | 1991-11-28 | — | — | WO | claimed |